Gilead Sciences Stock Analysis (Episode010)

Gilead Sciences is a biopharmaceutical company with a focus on treating and curing diseases. Their areas of focus include HIV, Hepatitis C, Oncology, Inflammation, and NASH.

Gilead Sciences (GILD)

- Business Model Overview
  - - HIV
    - Hepatitis C
    - Oncology/Cancer Treatment (KITE) – Yescarta
    - Inflammation – Filgotinib
    - NASH (Liver disease) – Selonsertib
      - Leading cause of liver transplants. Generally related to Obesity
    - Durability
    - Competition
    - Quality and Growth
    - Capital Allocation
    - Value
    - Potential Errors
    - Conclusion

Show Notes available at DIYInvesting.org

The full show notes for this episode, including my outline for today’s podcast, are available at https://www.diyinvesting.org/Episode6

Please review and rate the podcast

If you enjoyed this podcast and found it helpful, please consider leaving me a review. On an iOS platform such as an iPhone or iPad, you can do so by following these steps:

1. In your podcast app, click the search icon that looks like a magnifying glass in the bottom right-hand corner.
2. Type “The DIY Investing” into the search bar. This podcast should be one of the first shows that display.
3. Select the podcast show icon.
4. Scroll down to the “Ratings & Reviews Section” and click on the button that says “Write a Review”.
5. Write a short one or two sentence review and give me a rating that matches how you feel about the podcast.

Check out this episode!